Drug intelligence / Profile preview

personalized parenteral nutrition (Ospedali Riuniti Ancona)

Development stage
Unknown
Lead developer
Azienda Ospedaliero-Universitaria delle Marche
Modality
Small Molecules
Administration
Intravenous
01

Overview

Personalized parenteral nutrition (P-PN) is a tailored intravenous nutritional therapy used in the management of preterm infants. In the context of the Phase IV clinical trial conducted by Ospedali Riuniti Ancona (NCT03693287), P-PN involves the individual prescription and pharmacy-compounding of essential nutrients to meet the specific metabolic and growth requirements of infants with a birth weight greater than 1250 grams. The formulation typically includes dextrose 50% as a glucose source, Primene as an amino acid source, and Clinoleic as a lipid emulsion. This personalized approach is compared against standardized, ready-to-use multi-chamber bag formulations (such as Numeta G13%E) to evaluate its impact on neonatal growth and nutritional outcomes. The therapy provides essential macronutrients and micronutrients directly into the bloodstream when enteral feeding is insufficient or contraindicated.

Other names
personalized-parenteral nutrition-Ospedali Riuniti Ancona-prematurityPersonalized-parenteral nutrition

Beyond the preview

Go deeper on personalized parenteral nutrition (Ospedali Riuniti Ancona).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on personalized parenteral nutrition (Ospedali Riuniti Ancona).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call